Jennison Associates
CVS icon

Jennison Associates’s CVS Health CVS Stock Holding History

Jennison Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.5M Buy
942,869
+14,816
+2% +$1.32M 0.06% 168
2026
Q1 		$66.7M Sell
928,053
-467,906
-34% -$36M 0.05% 182
2025
Q4 		$111M Buy
1,395,959
+404,694
+41% +$31.9M 0.07% 122
2025
Q3 		$74.7M Sell
991,265
-3,022,874
-75% -$207M 0.04% 164
2025
Q2 		$277M Buy
4,014,139
+2,117,798
+112% +$139M 0.16% 68
2025
Q1 		$128M Buy
1,896,341
+1,582,257
+504% +$94.7M 0.09% 111
2024
Q4 		$14.1M Buy
+314,084
New +$17.6M 0.01% 371
2017
Q3 		– Sell
-9,808
Closed -$789K – 661
2017
Q2 		$789K Sell
9,808
-6,626
-40% -$523K ﹤0.01% 588
2017
Q1 		$1.29M Sell
16,434
-814
-5% -$65K ﹤0.01% 562
2016
Q4 		$1.36M Sell
17,248
-391,970
-96% -$31.7M ﹤0.01% 581
2016
Q3 		$36.4M Sell
409,218
-225,495
-36% -$21.3M 0.04% 325
2016
Q2 		$60.8M Sell
634,713
-85,210
-12% -$8.49M 0.07% 251
2016
Q1 		$74.7M Buy
719,923
+6,998
+1% +$680K 0.08% 214
2015
Q4 		$69.7M Sell
712,925
-302,486
-30% -$29.6M 0.07% 232
2015
Q3 		$98M Sell
1,015,411
-97,007
-9% -$10.2M 0.1% 185
2015
Q2 		$117M Sell
1,112,418
-132,212
-11% -$13.5M 0.11% 179
2015
Q1 		$128M Buy
1,244,630
+604,364
+94% +$61.2M 0.12% 170
2014
Q4 		$61.7M Buy
640,266
+27,218
+4% +$2.4M 0.06% 292
2014
Q3 		$48.8M Buy
613,048
+182,407
+42% +$14.4M 0.05% 335
2014
Q2 		$32.5M Sell
430,641
-409,499
-49% -$30.9M 0.03% 389
2014
Q1 		$62.9M Sell
840,140
-96,309
-10% -$6.8M 0.06% 287
2013
Q4 		$67M Sell
936,449
-21,761
-2% -$1.4M 0.07% 252
2013
Q3 		$54.4M Sell
958,210
-680,447
-42% -$40.5M 0.06% 283
2013
Q2 		$93.7M Buy
+1,638,657
New +$94.9M 0.11% 191

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates's CVS Position: Q2 2026 in Review

Jennison Associates increased its CVS Health (CVS) stake by 1.6% in Q2 2026, buying an estimated $1.32M and bringing the position to 942,869 shares worth $97.5M. The position accounts for 0.06% of the portfolio, ranked #168.

Jennison Associates first reported a position in CVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $277M in Q2 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Jennison Associates held 942,869 shares of CVS Health worth $97.5M as of Q2 2026.
  • Jennison Associates bought 14,816 CVS Health shares in Q2 2026, an estimated $1.32M.
  • CVS Health made up 0.06% of Jennison Associates's portfolio in Q2 2026, its #168 holding.
  • Jennison Associates first reported a position in CVS Health in Q2 2013 and has held it in 24 quarters since.
  • Jennison Associates's CVS Health position peaked at $277M in Q2 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.